Tesaro Summarizes Phase 3 Rolapitant Data Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting and Provides an Update on Niraparib Development Strategy
June 01, 2014 19:15 ET
|
TESARO, Inc.
Oral Rolapitant New Drug Application (NDA) Submission on Track for Mid-2014
Development Plans for Niraparib in Small Cell Lung Cancer and First-Line Ovarian Cancer Announced
CHICAGO, June...
Spectral Introduces Process Independent Reference Design IP for Memory Compilers Targeted for 20 nm and Lower Technologies
June 01, 2014 12:00 ET
|
Spectral Desgin & Test Inc
SOMERVILLE, NJ--(Marketwired - Jun 1, 2014) - Spectral Design & Test Inc. today announced design kits that complement the industry's most advanced Memory Development Platform (MDP) accelerating...
Immunomedics Reports Development of Improved Cancer Immunotherapy at the 2014 Annual Meeting of the American Society of Clinical Oncology
June 01, 2014 09:01 ET
|
Immunomedics, Inc.
-- T-cell Redirecting Immunotherapy Enhanced With Interferon-α in Human Pancreatic and Gastric Cancer Models --
CHICAGO, June 1, 2014 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU)...
Pivotal data for Novartis' investigational compound LDE225 show marked tumor responses in advanced basal cell carcinoma
June 01, 2014 09:00 ET
|
Novartis Pharma AG
The study met the primary endpoint with objective response rates of 41.8% and 32.5% respectively in the 200 mg and 800 mg treatment arms[1],[2] Basal cell carcinoma is the most common form of...
12th Annual Canadian Brewing Awards in Fredericton
June 01, 2014 09:00 ET
|
TAPS The Beer Magazine
FREDERICTON, NEW BRUNSWICK--(Marketwired - June 1, 2014) - On May 31st, the 12th annual Canadian Brewing Awards presentation was held at The Fredericton Convention Centre in Fredericton,...
Immunomedics Reports Final Efficacy Results of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan in Patients With Metastatic Pancreatic Cancer
June 01, 2014 09:00 ET
|
Immunomedics, Inc.
CHICAGO, June 1, 2014 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today reported an overall disease response rate of 41%, including 2 patients (7%) with partial response and 10 patients...
Novartis announces the appointment of Bruno Strigini as President of Novartis Oncology
June 01, 2014 08:00 ET
|
Novartis Pharma AG
Basel, June 1, 2014 - Novartis announced today the appointment of Bruno Strigini, as President of Novartis Oncology, effective June 1, 2014. Mr. Strigini joins Novartis from Merck & Co...
Louisville Veterinarian Says Summer Heartworm Protection a Must for Pet Health
June 01, 2014 07:00 ET
|
Audubon Animal Medical Center and Cherokee Animal Clinic
LOUISVILLE, Ky., June 1, 2014 (GLOBE NEWSWIRE) -- Audubon Animal Medical Center is reminding Louisville pet owners about the importance of protecting their dogs from heartworms, fleas and ticks this...
Nordic American Offshore Ltd. (NAO:OTC) Announces Proposed Offering in the PSV Sector to be Launched Monday June 2 before NYSE Opening
June 01, 2014 05:30 ET
|
Nordic American Offshore Ltd
Hamilton, Bermuda, June 1, 2014 Nordic American Offshore Ltd. (the "Company" or "NAO") announced today that it has filed a registration statement with the U. S. Securities and Exchange...
Nordic American Offshore Ltd. (NAO:OTC) Announces Proposed Offering in the PSV Sector to be Launched Monday June 2 before NYSE Opening
June 01, 2014 05:30 ET
|
Nordic American Tankers Limited
Hamilton, Bermuda, June 1, 2014 Press release about Nordic American Offshore Ltd. where Nordic American Tankers Limited (NAT:NYSE) owns 26% Nordic American Offshore Ltd. (the "Company" or "NAO")...